Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 18,600 shares, an increase of 500.0% from the October 31st total of 3,100 shares. Based on an average daily trading volume, of 116,500 shares, the short-interest ratio is currently 0.2 days.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group upgraded shares of Lonza Group to a “strong-buy” rating in a report on Wednesday, October 9th.
Read Our Latest Research Report on LZAGY
Lonza Group Stock Up 2.4 %
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Further Reading
- Five stocks we like better than Lonza Group
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to Invest in the Best Canadian StocksĀ
- 3 Penny Stocks Ready to Break Out in 2025
- How to Most Effectively Use the MarketBeat Earnings Screener
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.